UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The challenge of developing human 3D organoids into medicines

Stem cell research & therapy, 2020-03, Vol.11 (1), p.72-72, Article 72

2020

Volltextzugriff (PDF)

Towards the standardization of methods of tissue processing for the isolation of mesenchymal stromal cells for clinical use

Cytotechnology (Dordrecht), 2021-06, Vol.73 (3), p.513-522

2021

Volltextzugriff (PDF)

Beyond chimerism analysis: methods for tracking a new generation of cell-based medicines

Bone marrow transplantation (Basingstoke), 2020-07, Vol.55 (7), p.1229-1239

2020

Volltextzugriff (PDF)

Final results of a phase I–II trial using ex vivo expanded autologous Mesenchymal Stromal Cells for the treatment of osteoarthritis of the knee confirming safety and suggesting cartilage regeneration

The knee, 2016-08, Vol.23 (4), p.647-654

2016

Volltextzugriff (PDF)

HLA-DR expression in clinical-grade bone marrow-derived multipotent mesenchymal stromal cells: a two-site study

Stem cell research & therapy, 2019-06, Vol.10 (1), p.164-164, Article 164

2019

Volltextzugriff (PDF)

Strategies for large-scale expansion of clinical-grade human multipotent mesenchymal stromal cells

Biochemical engineering journal, 2020-07, Vol.159, p.107601, Article 107601

2020

Volltextzugriff (PDF)

Evaluation of a cell-based osteogenic formulation compliant with good manufacturing practice for use in tissue engineering

Molecular biology reports, 2020-07, Vol.47 (7), p.5145-5154

2020

Volltextzugriff (PDF)

Human Wharton’s jelly-derived mesenchymal stromal cells promote bone formation in immunodeficient mice when administered into a bone microenvironment

Journal of translational medicine, 2023-11, Vol.21 (1), p.1-802, Article 802

2023

Volltextzugriff (PDF)

Stability enhancement of clinical grade multipotent mesenchymal stromal cell-based products

Journal of translational medicine, 2018-10, Vol.16 (1), p.291-291, Article 291

2018

Volltextzugriff (PDF)

Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario?

Stem cell research & therapy, 2017-10, Vol.8 (1), p.238-238, Article 238

2017

Volltextzugriff (PDF)

Analysis of key indicators of research, development, and innovation in blood establishments and their impact on the delivery of improved quality health products and services

Global Journal of Transfusion Medicine, 2023-01, Vol.8 (1), p.57-61

2023

Volltextzugriff (PDF)

Osteogenic commitment of Wharton's jelly mesenchymal stromal cells: mechanisms and implications for bioprocess development and clinical application

Stem cell research & therapy, 2019-11, Vol.10 (1), p.356-356, Article 356

2019

Volltextzugriff (PDF)

Wharton’s Jelly Mesenchymal Stromal Cells and Derived Extracellular Vesicles as Post-Myocardial Infarction Therapeutic Toolkit: An Experienced View

Pharmaceutics, 2021-08, Vol.13 (9), p.1336

2021

Volltextzugriff (PDF)

The Quality Management Ecosystem in Cell Therapy in Catalonia (Spain): An Opportunity for Integrating Standards and Streamlining Quality Compliance

Cells (Basel, Switzerland), 2022-07, Vol.11 (13), p.2112

2022

Volltextzugriff (PDF)

Characterization of a Cytomegalovirus-Specific T Lymphocyte Product Obtained Through a Rapid and Scalable Production Process for Use in Adoptive Immunotherapy

Frontiers in immunology, 2020-02, Vol.11, p.271-271

2020

Volltextzugriff (PDF)

A pilot study of circulating levels of TGF-β1 and TGF-β2 as biomarkers of bone healing in patients with non-hypertrophic pseudoarthrosis of long bones

Bone Reports, 2022-06, Vol.16, p.101157-101157, Article 101157

2022

Volltextzugriff (PDF)

First-in-human PeriCord cardiac bioimplant: Scalability and GMP manufacturing of an allogeneic engineered tissue graft

EBioMedicine, 2020-04, Vol.54, p.102729-102729, Article 102729

2020

Volltextzugriff (PDF)

Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience

Frontiers in cardiovascular medicine, 2021-02, Vol.8, p.604434-604434

2021

Volltextzugriff (PDF)

Rmst is a novel marker for the mouse ventral mesencephalic floor plate and the anterior dorsal midline cells

PloS one, 2010-01, Vol.5 (1), p.e8641-e8641

2010

Volltextzugriff (PDF)

Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton’s Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory Compliance

Cells (Basel, Switzerland), 2022-07, Vol.11 (14), p.2153

2022

Volltextzugriff (PDF)

Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton's Jelly

Cells (Basel, Switzerland), 2019-05, Vol.8 (5), p.484

2019

Volltextzugriff (PDF)

Extracellular vesicles: Squeezing every drop of regenerative potential of umbilical cord blood

Metabolism, clinical and experimental, 2019-06, Vol.95, p.102-104

2019

Volltextzugriff (PDF)

Mesenchymal stromal cells in the treatment of pediatric hematopoietic cell transplantation-related complications (graft vs. host disease, hemorrhagic cystitis, graft failure and poor graft function): a single center experience

Frontiers in pediatrics, 2024-05, Vol.12, p.1375493-1375493

2024

Volltextzugriff (PDF)

Assessment of biodistribution using mesenchymal stromal cells: Algorithm for study design and challenges in detection methodologies

Cytotherapy (Oxford, England), 2017-09, Vol.19 (9), p.1060-1069

2017

Volltextzugriff (PDF)

Clinical-scale expansion of CD34+ cord blood cells amplifies committed progenitors and rapid scid repopulation cells

New biotechnology, 2017-03, Vol.35, p.19-29

2017

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(106)

Publikationsform

Artikel
(112)
Buchkapitel
(12)
Bücher
(2)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(87)
Life Sciences & Biomedicine
(82)
Humans
(39)
Cell Biology
(28)
Biotechnology & Applied Microbiology
(26)
Medicine, Research & Experimental
(23)
Research & Experimental Medicine
(23)
Animals
(21)
Cell & Tissue Engineering
(21)
Good Manufacturing Practice
(18)
Female
(17)
Bone Marrow
(16)
Cell Culture
(16)
Mesenchymal Stem Cells
(16)
Fibromyalgia
(15)
Hematology
(15)
Male
(15)
Stromal Cells
(14)
Mice
(13)
Cell Therapy
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The challenge of developing human 3D organoids into medicines

Towards the standardization of methods of tissue processing for the isolation of mesenchymal stromal cells for clinical use

Beyond chimerism analysis: methods for tracking a new generation of cell-based medicines

Final results of a phase I–II trial using ex vivo expanded autologous Mesenchymal Stromal Cells for the treatment of osteoarthritis of the knee confirming safety and suggesting cartilage regeneration

HLA-DR expression in clinical-grade bone marrow-derived multipotent mesenchymal stromal cells: a two-site study

Strategies for large-scale expansion of clinical-grade human multipotent mesenchymal stromal cells

Evaluation of a cell-based osteogenic formulation compliant with good manufacturing practice for use in tissue engineering

Human Wharton’s jelly-derived mesenchymal stromal cells promote bone formation in immunodeficient mice when administered into a bone microenvironment

Stability enhancement of clinical grade multipotent mesenchymal stromal cell-based products

Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario?

Analysis of key indicators of research, development, and innovation in blood establishments and their impact on the delivery of improved quality health products and services

Osteogenic commitment of Wharton's jelly mesenchymal stromal cells: mechanisms and implications for bioprocess development and clinical application

Wharton’s Jelly Mesenchymal Stromal Cells and Derived Extracellular Vesicles as Post-Myocardial Infarction Therapeutic Toolkit: An Experienced View

The Quality Management Ecosystem in Cell Therapy in Catalonia (Spain): An Opportunity for Integrating Standards and Streamlining Quality Compliance

Characterization of a Cytomegalovirus-Specific T Lymphocyte Product Obtained Through a Rapid and Scalable Production Process for Use in Adoptive Immunotherapy

A pilot study of circulating levels of TGF-β1 and TGF-β2 as biomarkers of bone healing in patients with non-hypertrophic pseudoarthrosis of long bones

First-in-human PeriCord cardiac bioimplant: Scalability and GMP manufacturing of an allogeneic engineered tissue graft

Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience

Rmst is a novel marker for the mouse ventral mesencephalic floor plate and the anterior dorsal midline cells

Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton’s Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory Compliance

Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton's Jelly

Extracellular vesicles: Squeezing every drop of regenerative potential of umbilical cord blood

Mesenchymal stromal cells in the treatment of pediatric hematopoietic cell transplantation-related complications (graft vs. host disease, hemorrhagic cystitis, graft failure and poor graft function): a single center experience

Assessment of biodistribution using mesenchymal stromal cells: Algorithm for study design and challenges in detection methodologies

Clinical-scale expansion of CD34+ cord blood cells amplifies committed progenitors and rapid scid repopulation cells

Suchergebnisse filtern